Department of Pathology Microbiology and Immunology

July 25, 2014

Treatments for frog fungus

The fungicide amphotericin B may be a useful treatment for a frog fungus that is killing amphibians worldwide.

By Leigh MacMillan
July 23, 2014

Natural killer cells don’t clear HMPV

Understanding how the immune system responds to the respiratory virus HMPV is crucial for developing vaccines and anti-viral treatments.

By Leigh MacMillan
July 18, 2014

Neural receptor for reovirus

A newly identified receptor allows mammalian reovirus to infect neurons, shedding light on factors important for viral encephalitis.

By Leigh MacMillan
July 17, 2014

Regulating immune regulators

Understanding how to control the generation of regulatory T cells could have important implications for treating autoimmunity and cancer.

By Leigh MacMillan
July 9, 2014

Study finds ‘hot’ frogs fight off fungal pathogen

Simple heat treatments may give the frog immune system a boost and help it fight off a deadly fungal pathogen, according to a new study published July 10 in the journal Nature.

By Leigh MacMillan
May 27, 2014

Respiratory virus vaccine candidate

Virus-like particles containing a protein from human metapneumovirus are a promising vaccine candidate for this respiratory virus.

By Leigh MacMillan
May 1, 2014

Cutting-edge research to be showcased in May

By Bill Snyder
April 28, 2014

Target cell entry to halt Chikungunya virus

Understanding how chikungunya virus binds to and enters cells offers a new target for antiviral medications.
By Leigh MacMillan
April 15, 2014

Anthrax bacteria’s signaling systems

Vanderbilt researchers have identified a new signaling system that anthrax bacteria uses to infect its host.
By Leigh MacMillan
March 27, 2014

Flu boosts pneumococcal colonization

Influenza and parainfluenza infections – but not other respiratory viruses – increase the risk of acquiring pneumococcal bacteria, the most common cause of severe pneumonia.
By VUMC News and Communications
March 20, 2014

Infection research symposium set for April 11

The latest research on pneumonic plague, respiratory syncytial virus (RSV) and other life-threatening infections will be discussed during a Symposium on Infection and Immunity April 11 at the Vanderbilt Student Life Center.
By Bill Snyder
March 3, 2014

Vanderbilt awarded $16.5 million agreement to determine how toxic agents affect human cells

Vanderbilt University has been awarded a Cooperative Agreement with the Defense Advanced Research Projects Agency and the Army Research Office that is worth up to $16.5 million over five years.
By Bill Snyder
January 15, 2014

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
By Leigh MacMillan
1 … 24 25 26 27 28 … 32